Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adial Pharmaceuticals, Inc. (ADIL)  
$0.24 0.00 (0.00%) as of 4:30 Fri 8/4


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 6,560,000
Market Cap: 1.55(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2023 - $0.385
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ADial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Co.'s investigational new drug product, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. Co. has a license from the University of Virginia Patent Foundation to commercialize its AD04. The active pharmaceutical agent in AD04, Co.'s investigational new drug product, is ondansetron, which is also the active ingredient in Zofran®, an approval for nausea and vomiting post-operatively and after chemotherapy or radiation treatment and is commercially available in generic form.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 700 700
Total Buy Value $0 $0 $1,918 $1,918
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 50
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schuyler Kevin Director   –       •      –    2023-09-29 4 B $2.74 $1,918 D/D 700 700 2.31     -
   Claiborne Cary J Chief Executive Officer   •       •      –    2023-05-23 4 A $0.00 $0 D/D 420,000 1,520,000     -
   Truluck Joseph Chief Financial Officer   •       –      –    2023-05-23 4 A $0.00 $0 D/D 157,500 265,139     -
   Stilley William B. Iii Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 240,800 1,261,779     -
   Stilley William B. Iii Director   –       •      –    2022-12-30 4 D $0.00 $0 D/D (166,667) 1,020,979     -
   Claiborne Cary J Chief Executive Officer   •       •      –    2022-09-20 4 A $0.42 $31,515 D/D 75,000 1,100,000     -
   Claiborne Cary J Chief Executive Officer   •       •      –    2022-09-19 4 A $0.43 $10,735 D/D 25,000 1,025,000     -
   Claiborne Cary J Chief Executive Officer   •       –      –    2022-08-18 4 A $0.00 $0 D/D 1,000,000 1,000,000     -
   Stilley William B. Iii Chief Executive Officer   •       •      –    2022-02-23 4 A $0.00 $0 D/D 250,000 1,187,646     -
   Newman James W. Jr. Director   –       •      –    2021-12-30 4 B $2.71 $40,700 I/I 15,000 34,644 2.1 -55%     
   Newman James W. Jr. Director   –       •      –    2021-12-30 4 B $2.66 $26,600 D/D 10,000 20,000 2.39 -55%     
   Schuyler Kevin Director   –       •       •   2021-12-23 4 GD $0.00 $0 D/D 312,990 0     -
   Newman James W. Jr. Director   –       •      –    2021-11-26 4 B $2.85 $28,500 I/I 10,000 34,475 2.1 -43%     
   Johnson Bankole A. Chief Medical Officer   •       –      –    2021-10-04 4 S $0.00 $0 I/I (200,000) 148,246 43%     
   Johnson Bankole A. Chief Medical Officer   •       –      –    2021-04-06 4 S $2.50 $375,000 I/I (150,000) 548,336 -31%     
   Stilley William B. Iii Chief Executive Officer   •       •       •   2021-01-26 4 A $0.00 $0 D/D 201,109 917,046     -
   Newman James W. Jr. Director   –       •      –    2021-01-26 4 A $0.00 $0 I/I 3,731 152,963     -
   Johnson Bankole A. Chief Medical Officer   •       –      –    2020-08-20 4 S $1.21 $423,500 D/D (350,000) 1,055 -15%     
   Newman James W. Jr. Director   –       •      –    2020-03-27 4 B $1.34 $19,669 I/I 14,644 14,644 2.1 48%     
   Newman James W. Jr. Director   –       •      –    2020-03-27 4 B $1.42 $7,100 D/D 5,000 15,000 2.39 48%     
   Stilley William B. Iii Chief Executive Officer   •       •       •   2020-03-26 4 B $1.47 $18,598 D/D 12,652 715,937 3.15 28%     
   Stilley William B. Iii Chief Executive Officer   •       •       •   2020-03-25 4 B $1.13 $13,953 D/D 12,348 703,285 3.15 61%     
   Truluck Joseph Chief Financial Officer   •       •      –    2020-03-03 4 A $0.00 $0 D/D 27,084 107,639     -
   Stilley William B. Iii Chief Executive Officer   •       •       •   2020-03-03 4 A $0.00 $0 D/D 54,167 690,937     -
   Johnson Bankole A. Chief Medical Officer   •       –       •   2019-12-12 4 S $1.00 $150,000 I/I (150,000) 698,336     -
  50 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us